
Loading articles...


CMS Adopts Performance-Based Standards for CRC Biomarker Tests
The Centers for Medicare & Medicaid Services (CMS) has implemented new performance-based standards for colorectal cancer (CRC) biomarker tests, despite ongoing questions regarding the clinical utility of some assays.

ctDNA Liquid Biopsy in Colorectal Cancer: Where the Evidence Sits Now
Three 2026 reviews map the current evidence for ctDNA and liquid biopsy in CRC detection and monitoring, and where integration lags behind the data.